Antibiotics

The EU is running out of experimental monkeys

Laboratory monkeys for medical trials have become scarce. China's export ban affects the European research landscape. A new EU rule further exacerbates the problem.

By Amelie Richter

When penicillin becomes a political issue

Skepticism was high early on about subjecting antibiotics to global price competition. Today, China is theoretically able to dictate the price of precursors. Only a handful of European companies still resist. Experts warn that the supply of vital pharmaceuticals is no longer guaranteed.

By Redaktion Table

Spahn: becoming independent with vital products

By

Cancer therapy: pharmaceutical companies to shake up the world market

China's pharmaceutical industry wants to play a role in the global market for cancer drugs with innovative biotech start-ups and inexpensive in-house developments. Chinese suppliers are teaming up with European and American partners to open up Western markets. Now, there is hope that the expensive treatment will become cheaper and possibly better because of the new competitive pressure from China.

By Frank Sieren